3/9/2023 0 Comments Bd hypack![]() "Since 2018, BD has added 350 million units of manufacturing capacity for glass barrel pre-fillable syringes, and this new commitment will invest in additional upgrades at all of our Pharmaceutical Systems manufacturing facilities and across multiple product categories. "BD invented the ready-to-fill, pre-fillable syringe technology, and today's announcement demonstrates our continued commitment to better serve our customers," said Eric Borin, worldwide president of BD Pharmaceutical Systems. The investment will also fund capacity expansion, new product innovations, manufacturing technology enhancements and business continuity improvements across its existing network, all designed to maximize supply and reduce risks for pharmaceutical companies that rely on ready-to-fill syringes for their injectable drugs - including complex biologics, vaccines and small molecules. The new manufacturing facility in Europe is expected to be operational by the end of 2023.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |